Ocugen (OCGN) Stock Forecast, Price Target & Predictions
OCGN Stock Forecast
Ocugen stock forecast is as follows: an average price target of $5.00 (represents a 313.22% upside from OCGN’s last price of $1.21) and a rating consensus of 'Buy', based on 5 wall street analysts offering a 1-year stock forecast.
OCGN Price Target
The average price target for Ocugen (OCGN) is $5.00 based on 1-year price targets from 5 Wall Street analysts in the past 3 months, with a price target range of $6.00 to $3.50. This represents a potential 313.22% upside from OCGN's last price of $1.21.
OCGN Analyst Ratings
According to 5 Wall Street analysts, Ocugen's rating consensus is 'Buy'. The analyst rating breakdown for OCGN stock is 0 'Strong Buy' (0.00%), 5 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Ocugen Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Aug 23, 2022 | Uy Ear | Mizuho Securities | $5.00 | $2.34 | 113.68% | 313.22% |
| Aug 15, 2022 | - | H.C. Wainwright | $6.00 | $2.88 | 108.33% | 395.87% |
| Jun 18, 2022 | Jennifer Kim | Cantor Fitzgerald | $4.50 | $2.16 | 108.33% | 271.90% |
| May 08, 2022 | Daniil Gataulin | Chardan Capital | $3.50 | $2.16 | 62.04% | 189.26% |
| Apr 25, 2022 | Zegbeh Jallah | Roth Capital | $6.00 | $2.40 | 150.00% | 395.87% |
The latest Ocugen stock forecast, released on Aug 23, 2022 by Uy Ear from Mizuho Securities, set a price target of $5.00, which represents a 113.68% increase from the stock price at the time of the forecast ($2.34), and a 313.22% increase from OCGN last price ($1.21).
Ocugen Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | - |
| Avg Price Target | - | - | - |
| Last Closing Price | $1.21 | $1.21 | $1.21 |
| Upside/Downside | -100.00% | -100.00% | -100.00% |
In the current month, the average price target of Ocugen stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Ocugen's last price of $1.21. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| May 15, 2024 | H.C. Wainwright | Buy | Buy | Hold |
| Mar 01, 2023 | Cowen & Co. | - | Outperform | Initialise |
| Jun 18, 2022 | Cantor Fitzgerald | Overweight | Overweight | Initialise |
| Apr 25, 2022 | Roth Capital | Buy | Buy | Hold |
| Jun 07, 2021 | Roth Capital | Buy | Buy | Hold |
| Feb 27, 2021 | H.C. Wainwright | Buy | Buy | Upgrade |
| Feb 09, 2021 | Chardan Capital | - | Buy | Downgrade |
| Feb 08, 2021 | Cantor Fitzgerald | Overweight | Overweight | Hold |
| Feb 06, 2021 | H.C. Wainwright | - | Buy | Upgrade |
| Feb 06, 2021 | Roth Capital | Buy | Buy | Hold |
Ocugen's last stock rating was published by H.C. Wainwright on May 15, 2024. The company gave OCGN a "Buy" rating, the same as its previous rate.
Ocugen Financial Forecast
Ocugen Revenue Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Dec 23 | Sep 23 | Dec 22 | Mar 22 | Dec 21 | Mar 21 | Jun 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | $42.62K |
| Avg Forecast | $1.14M | $1.14M | $1.14M | $1.14M | $400.00K | $400.00K | $1.14M | $6.04M | - | $2.17M | $13.87M | $13.87M | $39.04M | $8.97K |
| High Forecast | $1.14M | $1.14M | $1.14M | $1.14M | $400.00K | $400.00K | $1.14M | $6.04M | - | $2.17M | $13.87M | $16.64M | $39.04M | $10.77K |
| Low Forecast | $1.14M | $1.14M | $1.14M | $1.14M | $400.00K | $400.00K | $1.14M | $6.04M | - | $2.17M | $13.87M | $11.10M | $39.04M | $7.18K |
| # Analysts | - | - | - | - | 1 | 3 | 1 | 3 | 1 | 1 | 10 | 18 | 9 | 13 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 4.75% |
Ocugen's average Quarter revenue forecast for Mar 21 based on 9 analysts is $39.04M, with a low forecast of $39.04M, and a high forecast of $39.04M. OCGN's average Quarter revenue forecast represents a 91500.19% increase compared to the company's last Quarter revenue of $42.62K (Jun 20).
Ocugen EBITDA Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Dec 23 | Sep 23 | Dec 22 | Mar 22 | Dec 21 | Mar 21 | Jun 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | 1 | 3 | 1 | 3 | 1 | 1 | 10 | 18 | 9 | 13 |
| EBITDA | - | - | - | - | - | - | - | - | $-15.42M | $-24.15M | $-17.96M | $-14.48M | $-7.01M | $-3.35M |
| Avg Forecast | $-228.20K | $-228.20K | $-228.20K | $-228.20K | $-80.00K | $-80.00K | $-228.20K | $-1.21M | - | $-433.33K | $8.32M | $-12.13M | $-13.13M | $-8.28M |
| High Forecast | $-228.20K | $-228.20K | $-228.20K | $-228.20K | $-80.00K | $-80.00K | $-228.20K | $-1.21M | - | $-433.33K | $8.32M | $-9.71M | $-10.50M | $-6.63M |
| Low Forecast | $-228.20K | $-228.20K | $-228.20K | $-228.20K | $-80.00K | $-80.00K | $-228.20K | $-1.21M | - | $-433.33K | $8.32M | $-14.56M | $-15.75M | $-9.94M |
| Surprise % | - | - | - | - | - | - | - | - | - | 55.73% | -2.16% | 1.19% | 0.53% | 0.40% |
undefined analysts predict OCGN's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Ocugen's previous annual EBITDA (undefined) of $NaN.
Ocugen Net Income Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Dec 23 | Sep 23 | Dec 22 | Mar 22 | Dec 21 | Mar 21 | Jun 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | 1 | 3 | 1 | 3 | 1 | 1 | 10 | 18 | 9 | 13 |
| Net Income | - | - | - | - | - | - | - | - | $-14.16M | $-19.73M | $-18.00M | $-14.60M | $-7.08M | $-3.61M |
| Avg Forecast | $-18.01M | $-15.44M | $-15.44M | $-14.15M | $-13.73M | $-12.87M | $-13.73M | $-15.39M | $-17.95M | $-25.74M | $3.42M | $-12.15M | $-13.25M | $-8.94M |
| High Forecast | $-18.01M | $-15.44M | $-15.44M | $-14.15M | $-13.73M | $-10.29M | $-13.73M | $-13.19M | $-17.95M | $-25.74M | $3.42M | $-9.72M | $-10.60M | $-7.16M |
| Low Forecast | $-18.01M | $-15.44M | $-15.44M | $-14.15M | $-13.73M | $-12.87M | $-13.73M | $-17.59M | $-20.52M | $-25.74M | $3.42M | $-14.58M | $-15.90M | $-10.73M |
| Surprise % | - | - | - | - | - | - | - | - | 0.79% | 0.77% | -5.26% | 1.20% | 0.53% | 0.40% |
Ocugen's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. OCGN's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
Ocugen SG&A Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Dec 23 | Sep 23 | Dec 22 | Mar 22 | Dec 21 | Mar 21 | Jun 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | 1 | 3 | 1 | 3 | 1 | 1 | 10 | 18 | 9 | 13 |
| SG&A | - | - | - | - | - | - | - | - | $9.08M | $6.94M | $10.12M | $7.47M | $4.18M | $1.78M |
| Avg Forecast | $47.58M | $47.58M | $47.58M | $47.58M | $16.68M | $16.68M | $47.58M | $251.71M | - | $90.35M | $529.97M | $6.22M | $7.83M | $342.90K |
| High Forecast | $47.58M | $47.58M | $47.58M | $47.58M | $16.68M | $16.68M | $47.58M | $251.71M | - | $90.35M | $529.97M | $7.47M | $9.40M | $411.47K |
| Low Forecast | $47.58M | $47.58M | $47.58M | $47.58M | $16.68M | $16.68M | $47.58M | $251.71M | - | $90.35M | $529.97M | $4.98M | $6.27M | $274.30K |
| Surprise % | - | - | - | - | - | - | - | - | - | 0.08% | 0.02% | 1.20% | 0.53% | 5.19% |
Ocugen's average Quarter SG&A projection for Dec 23 is $251.71M, based on 3 Wall Street analysts, with a range of $251.71M to $251.71M. The forecast indicates a 2671.55% rise compared to OCGN last annual SG&A of $9.08M (Sep 23).
Ocugen EPS Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Dec 23 | Sep 23 | Dec 22 | Mar 22 | Dec 21 | Mar 21 | Jun 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | - | - | - | - | 1 | 3 | 1 | 3 | 1 | 1 | 10 | 18 | 9 | 13 |
| EPS | - | - | - | - | - | - | - | - | $-0.00 | $-0.09 | $-0.09 | $-0.07 | $-0.04 | $-0.04 |
| Avg Forecast | $-0.07 | $-0.06 | $-0.06 | $-0.06 | $-0.05 | $-0.05 | $-0.05 | $-0.06 | $-0.07 | $-0.10 | $0.01 | $-0.07 | $0.19 | $-0.04 |
| High Forecast | $-0.07 | $-0.06 | $-0.06 | $-0.06 | $-0.05 | $-0.04 | $-0.05 | $-0.05 | $-0.07 | $-0.10 | $0.01 | $-0.07 | $0.19 | $-0.04 |
| Low Forecast | $-0.07 | $-0.06 | $-0.06 | $-0.06 | $-0.05 | $-0.05 | $-0.05 | $-0.07 | $-0.08 | $-0.10 | $0.01 | $-0.07 | $0.19 | $-0.04 |
| Surprise % | - | - | - | - | - | - | - | - | 0.00% | 0.90% | -6.56% | 1.13% | -0.21% | 1.24% |
According to undefined Wall Street analysts, Ocugen's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to OCGN previous annual EPS of $NaN (undefined).
Ocugen Peer Comparison by Price Target
OCGN Forecast FAQ
Is Ocugen a good buy?
Yes, according to 5 Wall Street analysts, Ocugen (OCGN) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 5 'Buy' recommendations, accounting for 100.00% of OCGN's total ratings.
What is OCGN's price target?
Ocugen (OCGN) average price target is $5 with a range of $3.5 to $6, implying a 313.22% from its last price of $1.21. The data is based on 5 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Ocugen stock go up soon?
According to Wall Street analysts' prediction for OCGN stock, the company can go up by 313.22% (from the last price of $1.21 to the average price target of $5), up by 395.87% based on the highest stock price target, and up by 189.26% based on the lowest stock price target.
Can Ocugen stock reach $2?
OCGN's average twelve months analyst stock price target of $5 supports the claim that Ocugen can reach $2 in the near future.
What are Ocugen's analysts' financial forecasts?
Ocugen's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $1.94M (high $1.94M, low $1.94M), average EBITDA is $-388K (high $-388K, low $-388K), average net income is $-40.319M (high $-37.745M, low $-40.319M), average SG&A $80.94M (high $80.94M, low $80.94M), and average EPS is $-0.157 (high $-0.147, low $-0.157). OCGN's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $4.56M (high $4.56M, low $4.56M), average EBITDA is $-913K (high $-913K, low $-913K), average net income is $-63.052M (high $-63.052M, low $-63.052M), average SG&A $190.33M (high $190.33M, low $190.33M), and average EPS is $-0.245 (high $-0.245, low $-0.245).
Did the OCGN's actual financial results beat the analysts' financial forecasts?
In terms of the last quarterly report (Jun 2020), Ocugen's revenue was $42.62K, beating the average analysts' forecast of $8.97K by 375.03%. The company's EBITDA was $-3.346M, missing the average prediction of $-8.282M by -59.60%. Ocugen's net income was $-3.614M, missing the average estimation of $-8.945M by -59.60%. The company's SG&A was $1.78M, beating the average forecast of $342.9K by 418.81%. Lastly, the company's EPS was $-0.0433, beating the average prediction of $-0.035 by 23.60%